Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-administration of Priorix-Tetra and NeisVac-C in healthy children 12-23 months
2008-003318-81Phase 4Terminated
- Sponsor
- GSK
- Start
- Sep 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of GSK208136 and Meningococcal group C polysaccharide conjugate vaccine in measles, mumps, rubella and 2 more (2 arms), sponsored by GSK. Primary endpoint: Immunogenicity non-inferiority. Started Sep 2008; status: terminated.
02
Drugs
GSK208136Meningococcal group C polysaccharide conjugate vaccine
03
Conditions
measlesmumpsrubellachickenpoxmeningococcal disease
Beyond the preview
Go deeper on 2008-003318-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003318-81.